French Tech News: VivaTech-A-Palooza
It's VivaTech time. We give you a rundown of the 21 French startups with unicorn potential; Plus a Q&A with one of the conference's founders.
Latest
VivaTech: 21 Future French Unicorns
VivaTech has anointed its Top 100 Next Unicorns for the latest edition of the conference. Here's the rundown of the French candidates who hope to be the Next Big Thing.
Spotlight Interview: VivaTech's Nicolas Douchement
"This year feels more optimistic, like the beginning of a new era."
The Big Deals 💣 : Resilience, H, And May Health
GenAI (of course), and MedTech get new checks.
Seed Scout #15: Avatar Medical Visualizes Healthcare's 3D Future
Also inside: Masawa Managing Partner Sabine Flechet discusses the new mental health early-stage fund; and Seed Deals.
Investor Spotlight: Masawa Partner Sabine Flechet
Munich-based Sabine Flechet is a prominent Business Angel who launched an early-stage fund that backs mental-health startups but also supports the mental health of founders through its approach dubbed, "Nurture Capital."
🔥Hot Seed Deals: Hephaistos-Pharma, VoltR, Klineo & Edonia
Deep Tech and Health Tech continue to attract early-stage investors.
Seed Of The Week: Avatar Medical
CEO and Co-Founder Xavier Wartelle explains how a recent €5 million Seed Round will be used to accelerate the rollout of the company's 3D Extended Reality imaging technology.
French Tech News: SNCF Digital Plans Go Full Steam Ahead
Also inside: How Qubit Pharmaceuticals will use quantum computing to reinvent drug discovery; AI startups continue to make VCs swoon.
Next Stop: SNCF's €2bn Digital Plan To Reinvent Rail Travel
France's train company is investing in AI, robots, and data. SNCF's Christophe Fanichet: “If we want to remain the leader in mobility, there is no choice but to be a leader in tech."
The Big Deals 💣 : FlexAI, Payflows, And BforeAI
AI continues to be a money magnet while B2B fintech gets a nod.
Spotlight Interview: Qubit Pharmaceuticals' Robert Marino And Jean-Philip Piquemal
Piquemal on the future of drug discovery: "Quantum computing will be...capable of predicting quickly and with accuracy the chemical processes we are looking at. And if we can predict, we can go faster."
Seed Scout #14: Kolet's eSIM Plot To Reinvent Telecom Services
Also inside: Serena Partner Bertrand Diard breaks down the firm's new €100m Data and AI fund; and the latest Seed Deals.
Seed Of The Week: Kolet
Kolet raised €5m to develop an eSIM platform for international travelers. It's the first step of CEO Eduardo Ronzano's long-term vision of connecting billions of people to the internet by reinventing the telecom industry.
🔥Hot Seed Deals: Blackleaf, Veesual, Hylight & More
Also inside: Estaly, United Visual Researchers, Reverto, and Mayam.
Investor Spotlight: Serena Partner Bertrand Diard
Thanks to an early bet on Data and AI, Serena was able to raise a new €100m early-stage fund to expand its investments in one of tech's hottest spaces.